Rahul Nanchal, MD
Pulmonary Disease · Milwaukee, WINPI 1619929320
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $37,900 of the $41,511 with a category attached, or 91.3%. Mallinckrodt Hospital Products Inc. accounts for 86.5% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $35,911, more than ten times the $77 reported in 2019. Among pulmonary disease clinicians in WI with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 36 payments — averaging $1153.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mallinckrodt Hospital Products Inc.$36K
- Pfizer$6K
- Beckman Coulter, Inc.$77
- Advanced Respiratory, Inc$24
Across 47 payments — averaging $2439.11 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Dompe Farmaceutici S.p.a.$76K
- Roche Products Limited$38K
What the payments were for
- Speaking & faculty fees$37,90091%
- Travel & lodging$3,0627%
- Food & beverage$5161%
- Education$330%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mallinckrodt Hospital Products Inc. | 30 | $35,911 |
| Pfizer | 4 | $5,500 |
| Beckman Coulter, Inc. | 1 | $77 |
| Advanced Respiratory, Inc | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TERLIVAZ$35,375
How this compares
$41,511 in reported general payments places this provider in the 95th percentile of 247 pulmonary disease providers in Wisconsin.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pulmonary disease in Milwaukee
- Jonathan KurmanMilwaukee$803K
- Mouhammed RihawiMilwaukee$713K
- Kurt HuMilwaukee$55K
- Julie BillerMilwaukee$52K
- Mark BarashMilwaukee$52K
- Steven LehMilwaukee$40K
- Ali MusaniMilwaukee$38K
- Michael KatzoffMilwaukee$37K
- Uzair GhoriMilwaukee$32K
- Jayshil PatelMilwaukee$25K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.